AngioDynamics reported $2 million in income in the second quarter of fiscal year 2013, which ended Nov. 30. This was down from $2.3 million one year earlier for a drop of $0.03 a share.
The Latham-based manufacturer of medical devices experienced net sales of $87 million in the second quarter, up 50 percent from $58.1 million reported one year earlier. Second-quarter costs included the acquisition of Navilyst Medical in May 2012 and a restructuring of the company last fall.
“We improved our performance in the fiscal second quarter,” said AngioDynamics president and CEO Joseph DeVivo in a Jan. 3 statement to investors.
He pointed to international product offerings for oncology and surgery fields, and the addition of new devices as reasons for the company’s growth.
“AngioDynamics’ financial performance continues to improve, and we are excited about our future growth opportunities,” he said.